Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account by Malik Osmane, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Malik Osmane ISBN: 9783656517382
Publisher: GRIN Verlag Publication: October 15, 2013
Imprint: GRIN Verlag Language: English
Author: Malik Osmane
ISBN: 9783656517382
Publisher: GRIN Verlag
Publication: October 15, 2013
Imprint: GRIN Verlag
Language: English

Master's Thesis from the year 2013 in the subject Medicine - Pharmacology, grade: 1 st CLASS HONS, Dublin Institute of Technology (Chemistry), course: Pharmaceutical Quality Assurance / Regulatory Affairs, language: English, abstract: During the course of this thesis evidence was presented and discussed related to the research questions. The fundamental question related to the heterogeneity and variation through the life cycle of the biosimilar and the reference biologic remains neglected, based on the results collected during this thesis, by the stakeholders, mainly because those issues where not addressed in any official regulatory guidance document. As clear guidance from the EMA is lacking, with the only available guidance being that once a marketing authorization is issued it is accepted that the quality profiles of the reference biologic and the biosimilar will have different quality profiles. Abstract: Within the biosimilar development context, there are unaddressed questions by the European Medicines Agency (EMA) with regard to the impacts of shifts of the quality profile (purity- and impurity levels) of the reference biologic for the biosimilar development program. This dynamic is an open issues has potentially implications on the comparability exercise of the before mentioned. Opinions from experts involved in the guidance drafting process of EMA and other were evaluated with regard to the issue.[...]

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Master's Thesis from the year 2013 in the subject Medicine - Pharmacology, grade: 1 st CLASS HONS, Dublin Institute of Technology (Chemistry), course: Pharmaceutical Quality Assurance / Regulatory Affairs, language: English, abstract: During the course of this thesis evidence was presented and discussed related to the research questions. The fundamental question related to the heterogeneity and variation through the life cycle of the biosimilar and the reference biologic remains neglected, based on the results collected during this thesis, by the stakeholders, mainly because those issues where not addressed in any official regulatory guidance document. As clear guidance from the EMA is lacking, with the only available guidance being that once a marketing authorization is issued it is accepted that the quality profiles of the reference biologic and the biosimilar will have different quality profiles. Abstract: Within the biosimilar development context, there are unaddressed questions by the European Medicines Agency (EMA) with regard to the impacts of shifts of the quality profile (purity- and impurity levels) of the reference biologic for the biosimilar development program. This dynamic is an open issues has potentially implications on the comparability exercise of the before mentioned. Opinions from experts involved in the guidance drafting process of EMA and other were evaluated with regard to the issue.[...]

More books from GRIN Verlag

Cover of the book Das Pflegephänomen Sturz. Eine Annäherung durch NANDA-Pflegediagnosen zur Verbesserung der Pflegequalität by Malik Osmane
Cover of the book Die Erkenntnisse des Kognitivismus und Jean Piagets als Ansatz bei der Konzeption von Lernsoftware? by Malik Osmane
Cover of the book Die Industrialisierung Japans - Eine spezifisch japanische Entwicklung by Malik Osmane
Cover of the book Das Europäische Parlament und das Demokratiedefizit der EU. Das Legitimationspotential des Europäischen Parlaments by Malik Osmane
Cover of the book Vendor Managed Inventory als Steuerungskonzept in der Automobilindustrie dargestellt am Beispiel der Blaupunkt GmbH by Malik Osmane
Cover of the book Erklärungsmodelle des Wahlverhaltens by Malik Osmane
Cover of the book Diskriminanzanalysen im Rahmen von Bilanzanalysen zur Bonitätsbewertung by Malik Osmane
Cover of the book Über die Notwendigkeit: Der Ananke-Begriff in Platons 'Timaios' by Malik Osmane
Cover of the book Führt eine flache Hierarchie zu größerer Effizienz? Ein Vergleich verschiedener Führungspsychologien by Malik Osmane
Cover of the book Entstehung und Geschichte der Grünen - Politische Strömungen, Formierung und Parteigründung in Karlsruhe 1980 by Malik Osmane
Cover of the book Ansätze der modernen Budgetierung by Malik Osmane
Cover of the book The Picture of Reality and History in Julian Barnes' 'A History of the World in 10 1/2 Chapters' by Malik Osmane
Cover of the book Nervöse Zeiten. Auswirkungen unserer beschleunigten Lebensweise by Malik Osmane
Cover of the book Die Konstantinische Wende im Urteil der modernen deutschsprachigen Forschungsliteratur by Malik Osmane
Cover of the book Folgen von Gewalt für die Opfer by Malik Osmane
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy